deupirfenidone
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2020 (NCT04243837)
Timeline
Indications
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Loading structure…
SMILES
[2H]C([2H])([2H])c1ccc(=O)n(-c2ccccc2)c1- Mol. weight
- 188.24 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095176 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07284602 | Phase 3 | Apr 30, 2026 | PureTech |
| NCT05321420 | Phase 2 | Jul 29, 2022 | PureTech |
| NCT04652518 | Phase 2 | Dec 11, 2020 | Clinipace LTD, Novotech, PureTech, University of Southern California |
| NCT04243837 | Phase 1 | Mar 1, 2020 | Novotech, PureTech |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PureTech | For profit | 4 | 4 | 3 | 2020 |
| Novotech | For profit | 2 | 0 | 2 | 2020 |
| Clinipace LTD | For profit | 1 | 0 | 1 | 2020 |
| University of Southern California | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1